Where it comes from
- Made in
- Liver, kidney and muscle in the mouse; found in blood, where it falls with age
- Sent out by
- Unknown; plasma levels are lower in old mice than in young ones
- Acts on
- Neurons
- Fat cells (differentiation)
- Islet and liver cells
What it does
- Protects cells from oxidative stress, cuts apoptosis and improves mitochondrial respiration, the closest of the six to humanin 1
- Infused into the brain of rats it raised glucose uptake and suppressed the liver’s glucose output, so it acts as an insulin sensitiser from the brain outwards 1
- The one SHLP with a human genetic finding: m.2158T>C puts an arginine where a lysine was (K4R), and that form is more stable and goes with less Parkinson’s disease 3
In medicine
Beyond the body’s own use
- Nothing is in trials. SHLP2 is the one of the six that has been given to living animals, by brain infusion and by injection, which is why most of what is known about the family comes from it 1
- Its human evidence is the strongest of these peptides apart from humanin and SHMOOSE, and it is genetic rather than therapeutic 3
- It is not taken outside medicine, and no preparation of it is approved anywhere
Sources
- Cobb et al., Mitochondrial-derived peptides are age-dependent regulators of apoptosis and insulin sensitivity, Aging 2016
- Xiao et al., Low circulating levels of SHLP2 as a biomarker for prostate cancer risk, Oncotarget 2017
- Kim et al., A naturally occurring variant of SHLP2 is a protective factor in Parkinson’s disease, Molecular Psychiatry 2024
This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.